New Vector Innovation for Drug Delivery: Development of Fusigenic Non- Viral Particles

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|4|8|599-602

ISSN： 1389-4501

Source： Current Drug Targets, Vol.4, Iss.8, 2003-11, pp. : 599-602

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous System

By Pérez-Martínez Francisco   Guerra Javier   Posadas Inmaculada   Ceña Valentín  

Pharmaceutical Research, Vol. 28, Iss. 8, 2011-08 ,pp. : 1843-1858

Springer Publishing Company

Access to resources Recommend Favorite

Advances in the Development of Non-Human Viral DNA-Vectors for Gene Delivery

By  

Current Gene Therapy, Vol. 2, Iss. 2, 2002-01 ,pp. : 161-171

Bentham Science Publishers

Access to resources Recommend Favorite

The Impact of Nanobiotechnology on the Development of New Drug Delivery Systems

By  

Current Pharmaceutical Biotechnology, Vol. 6, Iss. 1, 2005-02 ,pp. : 3-5

Bentham Science Publishers

Access to resources Recommend Favorite

Development of New Antituberculous Drugs: Strategies for New Drug Targets and Drug Delivery

By  

Drug Design Reviews - Online, Vol. 2, Iss. 6, 2005-09 ,pp. : 427-434

Bentham Science Publishers

Access to resources Recommend Favorite

New Strategies for Immune-Mediated Anti-Viral Drug and Vaccine Development

By  

Current Pharmaceutical Design, Vol. 12, Iss. 11, 2006-04 ,pp. : 1391-1401

Bentham Science Publishers

Access to resources Recommend Favorite